drugset / Trial / NCT01334918
A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)
RandomizedCrossoverOpen-labelDiagnostic
Summary
The purpose of this study is to compare Multidetector Computed Tomography (MDCT) and Single Photon Emission Computed Tomography (SPECT) stress myocardial perfusion imaging (MPI) with regadenoson in order to detect the presence or absence of reversible defects.
Timeline
- Start
- 2011-04-26
- Primary completion
- 2012-07-02
- Completion
- 2012-07-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Regadenoson | Diagnostic / imaging agent | 0.4 mg | Intravenous |